A literature review conducted on the treatment of leukemia with the BCR::FGFR1 translocation underscores the importance and effectiveness of allogeneic hematopoietic SCT as a primary therapy to achieve molecular remission in acute leukemia (as seen in Table 1). The gene discussed is FGFR1; the disease is leukemia.